Is olomoucine, a weak CDK2 inhibitor, able to induce apoptosis in cancer cells?

Annals of the New York Academy of Sciences

Volumn 1171, Issue , 2009, Pages 242-249

  Wandl, Stefanie ^a   Wȩsierska Ga̧dek, Józefa ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; CDKs; Cell cycle arrest; G1 arrest; p53 tumor suppressor; Pharmacological CDK inhibitors

Indexed keywords

DNA; OLOMOUCINE;

APOPTOSIS; CANCER CELL; CARCINOGENESIS; CELL COUNT; CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL KINETICS; CELL POPULATION; CELL PROLIFERATION; CELL STRAIN HL 60; CELL VIABILITY; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DNA CONTENT; FIBROBLAST; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; UTERINE CERVIX CARCINOMA;

EID: 69149092103     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04700.x     Document Type: Conference Paper

References (31)

1. Nurse, P. 2002. Cyclin-dependent kinases and cell cycle control (Nobel lecture). Chembiochem 3 : 596 603.
2. Senderowicz, A.M. 2003. Small-molecule cyclin-dependent kinase modulators. Oncogene 22 : 6609 6620.
3. Sherr, C.J. J.M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13 : 1501 1512.
4. Weinberg, R.A. 1996. The molecular basis of carcinogenesis: understanding the cell cycle clock. Cytokines Mol. Ther. 2 : 105 110.
5. Blagosklonny, M.V. 2002. p53: an ubiquitous target of anticancer drugs. Int. J. Cancer 98 : 161 166.
6. Schmid, G., M. Maurer, M.P. Kramer, et al. 2007. Cellular and organismal ageing: role of the p53 tumor suppressor protein in the induction of transient and terminal senescence. J. Cell. Biochem. 101 : 1355 1369.
7. Donehower, L.A. A. Bradley. 1993. The tumor suppressor p53. Biochim. Biophys. Acta 1155 : 181 205.
8. Bargonetti, J. J.J. Manfredi. 2002. Multiple roles of the tumor suppressor p53. Curr. Opin. Oncol. 14 : 86 91.
9. el-Deiry, W.S., T. Tokino, V.E. Velculescu, et al. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75 : 817 825.
10. Dalla-Favera, R., et al. 1982. Oncogene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient. Nature 299 : 61 63.
11. Wolf, D. V. Rotter. 1985. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cell. Proc. Natl. Acad. Sci. USA 82 : 790 794.
12. Banerjee, D., H.J. Lenz, et al. 1995. Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress. Cell Growth Differ. 6 : 1405 1413.
13. Durst, M., C.M. Croce, L. Gissmann, et al. 1987. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc. Natl. Acad. Sci. USA 84 : 1070 1074.
14. Scheffner, M., B.A. Werness, J.M. Huibregtse, et al. 1990 : The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 : 1129 1136.
15. Slebos, R.J., M.H. Lee, B.S. Plunkett, et al. 1994. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91 : 5320 5324.
16. Edamatsu, H., C.L. Gau, T. Nemoto, et al. 2000. Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines. Oncogene 19 : 3059 3068.
17. Wojciechowski, J., M. Horky, M. Gueorguieva J. Wesierska-Gadek. 2003. Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells. Int. J. Cancer 106 : 486 495.
18. Wesierska-Gadek, J., M. Gueorguieva M. Horky. 2003. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin. Pol. J. Pharmacol. 55 : 895 902.
19. Wesierska-Gadek, J. G. Schmid. 2006. Dual action of the inhibitors of cyclin-dependent kinases: targeting of the cell-cycle progression and activation of wild-type p53 protein. Expert Opin. Investig. Drugs 15 : 23 38.
20. De Azevedo, W.F., S. Leclerc, L. Meijer, et al. 1997. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur. J. Biochem. 243 : 518 526.
21. Gray, N., L. Détivaud, C. Doerig L. Meijer. 1999. ATP-site directed inhibitors of cyclin-dependent kinases. Curr. Med. Chem. 6 : 859 875.
22. Meijer, L., A. Borgne, O. Mulner, et al. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243 : 527 536.
23. Wesierska-Gadek, J., M. Gueorguieva, M.P. Kramer, et al. 2007. A new, unexpected action of olomoucine, a CDK inhibitor, on normal human cells: up-regulation of CLIMP-63, a cytoskeleton-linking membrane protein. J. Cell Biochem. 102 : 1405 1419.
24. Wesierska-Gadek, J., D. Schloffer, M. Gueorguieva, et al. 2004. Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest. Cancer Res. 64 : 4487 4497.
25. Wesierska-Gadek, J. G. Schmid. 2000. Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint. J. Cell. Biochem. 80 : 85 103.
26. Vindeløv, L.L., I.J. Christensen N.I. Nissen. 1983. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3 : 323 327.
27. Wesierska-Gadek, J., D. Schloffer, V. Kotala M. Horky. 2002. Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy. Int. J. Cancer 101 : 128 136.
28. Wesierska-Gadek, J., M. Gueorguieva, O. Komina, et al. 2008. Signaling of DNA damage is not sufficient to induce p53 response: (re)activation of wt p53 protein strongly depends on cellular context. J. Cell Biochem. 103 : 1607 1620.
29. Wesierska-Gadek, J., M. Gueorguieva, C. Ranftler G. Zerza-Schnitzhofer. 2005. A new multiplex assay allowing simultaneous detection of the inhibition of cell proliferation and induction of cell death. J. Cell Biochem. 96 : 1 7.
30. Wang, X. G.P. Studzinski. 1997. Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp. Cell Res. 235 : 210 217.
31. Shiekhattar, R., F. Mermelstein, R.P. Fischer, et al. 1995. CDK-activating kinase complex is a component of human transcription factor TFIIH. Nature 374 : 283 287.